
LDN-192960
CAS No. 184582-62-5
LDN-192960 ( —— )
产品货号. M23838 CAS No. 184582-62-5
LDN-192960 是 Haspin 和 DYRK2 的有效抑制剂(IC50:10 nM 和 48 nM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1320 | 有现货 |
![]() ![]() |
10MG | ¥2130 | 有现货 |
![]() ![]() |
25MG | ¥4277 | 有现货 |
![]() ![]() |
50MG | ¥6229 | 有现货 |
![]() ![]() |
100MG | ¥8748 | 有现货 |
![]() ![]() |
500MG | ¥17496 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称LDN-192960
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LDN-192960 是 Haspin 和 DYRK2 的有效抑制剂(IC50:10 nM 和 48 nM)。
-
产品描述LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM).
-
体外实验LDN-192960 (10 μM) is selective and inhibits ten of the other kinases by ≥90%, with only five being potently inhibited (IC50<1 μM),including CLK1 (IC50=0.21 μM), DYRK1A(IC50= 0.10 μM), DYRK2 (IC50=2 nM), DYRK3 (IC50=19 nM) and PIM1 (IC50=0.72 μM).LDN-0192960 (0-5 μM; 2 hours) demonstrates that the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells overexpressing Haspin with an EC50 of 1.17 μM. LDN-0192960 (0-1 μM; 1 hour incubation in the presence of nocodazole and MG132) demonstrates the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells synchronized in mitosis with an EC50 of 0.02 μM.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体DYRK2| Haspin
-
研究领域——
-
适应症——
化学信息
-
CAS Number184582-62-5
-
分子量328.43
-
分子式C18H20N2O2S
-
纯度>98% (HPLC)
-
溶解度DMSO:30 mg/mL (91.34 mM);Water:10 mg/mL (30.45 mM)
-
SMILESNCCCSC1=C(C=C(OC)C=C2)C2=NC3=CC=C(OC)C=C31
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Cuny GD, et al. Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3491-4.
产品手册




关联产品
-
Dehydrojuncusol
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.
-
Lumazine
Lumazine 是一种用于复杂(磷酸)脂质混合物分析的新型 MALDI 基质。
-
RTICBM-189
RTICBM-189 具有脑渗透性,可减弱可卡因寻求行为的恢复。